Apple Tree Partners Recruits Noted Biotech Entrepreneur and Computer-Aided Drug Design Pioneer Matthew P. Jacobson, Ph.D., as New Venture Partner
NEW YORK and SOUTH SAN FRANCISCO, Calif., July 11, 2023 /PRNewswire/ -- Apple Tree Partners (ATP), a leader in life sciences venture capital, announced today that Matthew P. Jacobson, Ph.D., serial biotech entrepreneur and Professor Emeritus in the Department of Pharmaceutical Chemistry at University of California San Francisco (UCSF), has joined ATP as a venture partner. In this role, he will identify opportunities for new life sciences investments and company creation and provide strategic expertise to ATP's portfolio companies. He will be based in ATP's South San Francisco office.
- In this role, he will identify opportunities for new life sciences investments and company creation and provide strategic expertise to ATP's portfolio companies.
- Dr. Jacobson's research interests are in the areas of computational biophysics and computer-aided drug design; he is the author of more than 200 publications and several patents.
- He presently devotes most of his time to biotech entrepreneurship and has co-founded six successful biotech companies in the past dozen years.
- "We have enjoyed a productive working relationship with Matt for several years, and we are delighted to formally welcome him to ATP as a venture partner and scientific advisor," said Seth Harrison, M.D., Apple Tree Partners' founder and Managing Partner.